Congress speakers OT 2021
Dutch Veterinary Oncology Conference, the virtual experience!
These are our speakers:
Prof. dr. Arjan Griffioen
Professor of Experimental Oncology and Angiogenesis, Head Angiogenesis Laboratory
Director of the Graduate School for Oncology Amsterdam (OOA)
I am working on making a vaccine for therapy and prevention of cancer. I am a professor of cancer biology specialized in tumor immunology and angiogenesis at Amsterdam UMC. With my team, the Angiogenesis Laboratory, we are focusing on vaccines that target the tumor vasculature. This approach is effective and safe and does not induce drug resistance. We are currently bringing the first vaccine into clinical testing.
Next to my practical research activities I have the following functions:
Director of the Graduate School for Oncology Amterdam (OOA)
Director of the Master Oncology program at the VU University Amterdam
Editor-in-Chief of the scientific journal Angiogenesis
Founder and Chief Scientific Officer of CimCure BV
Prof. dr. Henrik Rönnberg
European Veterinary Specialist in Oncology
Prof Internal Medicine, companion animals
Henrik is a European Specialist and National Recognized Specialist in Veterinary Oncology. He is the head of the University Animal Hospital Oncology Service at the Swedish University of Agricultural Sciences (SLU). He is programme director of the oncology residency programme at SLU. His research interests include canine lymphoma, mammary tumors, malignant melanoma, biomarkers and immunotherapy. He is the founder of the Center of Clinical Comparative Oncology (C3O) and particularly interested in comparative genomics.
Henrik graduated from the Swedish University of Agricultural Sciences (SLU) Veterinary School in 1994 and finished his PhD in 2002 in veterinary surgery (oncology) at the Dept of Small Animal Clinical Sciences (SLU), joint project with the Karolinska Institutet (KI) Stockholm, Sweden. He became Associate Prof 2007 in veterinary internal medicine, Dept of Clinical Sciences (SLU) and Professor 2012 in veterinary internal medicine at the same department. He became a Diplomate of the European College of Veterinary Internal Medicine and a European Veterinary Specialist in Oncology in 2009. He is the head of the busy University Animal Hospital Oncology Service at SLU. He has also long been active within the drug industry designing clinical trials and consulting in communication with medical product agencies such as EMA and FDA-CVM. He has been part time employed as Chief Medical Officer (CMO) at Oasmia Pharmaceutical AB in Uppsala, developing new cancer drugs for dogs and humans. He is a popular speaker, always trying to get difficult topics understandable. He is currently serving as Deputy Dean for clinical relations at the Faculty of Veterinary Medicine and Animal Sciences at SLU.
Dr. Gerry Polton
MA VetMB MSc (Onc) DipECVIM (Oncology) MRCVS, RCVS Specialist in Veterinary Oncology, EBVS® European Veterinary Specialist in Small Animal Oncology
Gerry graduated from Cambridge Veterinary School in 1997, after which he initially worked in first opinion practice. He entered specialist practice as a clinical oncologist in 2002. Gerry was awarded a Master of Science degree in clinical oncology by the Institute of Cancer Research at Birmingham University in 2003, having presented a thesis on the subject of canine anal sac tumours, a subject on which he is a world expert.
He became a Diplomate of the European College of Veterinary Internal Medicine and a European recognised Specialist in Oncology in 2010 and an RCVS recognised Specialist in Oncology in 2012.
Gerry has published scientific literature and lectured across the world on a range of cancer subjects including lymphoma, mast cell tumours, lung tumours, insulin-producing tumours and novell anti-cancer therapies; he chairs and participates in a number of European oncology research projects and has a particular interest in collaborative clinical research. Gerry is Director of the Oncology Service at North Downs Specialist Referrals.